ImYoo is a company headquartered in the United States.
ImYoo is a Public Benefit Corporation that enables patients to participate in precision medicine by collecting immune system samples at home for molecular profiling to support research and personalized health insights.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.